Cell-mediated reduction of human β-defensin 1: A major role for mucosal thioredoxin

Mucosal Immunology

Volumn 6, Issue 6, 2013, Pages 1179-1190

  Jaeger, S U ^a,b,d   Schroeder, B O ^b,d   Meyer Hoffert, U ^c   Courth, L ^b,d   Fehr, S N ^b,d   Gersemann, M ^a   Stange, E F ^a   Wehkamp, J ^a,b,d  

^a ROBERT BOSCH HOSPITAL   (Germany)

^b DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 1; GLUTAREDOXIN; POLYPEPTIDE ANTIBIOTIC AGENT; THIOREDOXIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CATALYSIS; CELL MEDIATED REDUCTION; CELL VIABILITY; COLON MUCOSA; CONTROLLED STUDY; ENTERITIS; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE CELL; LYMPHOID CELL; MAJOR CLINICAL STUDY; MALE; MEMBRANE BINDING; OXIDATION REDUCTION REACTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REDUCTION; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; AURANOFIN; BETA-DEFENSINS; BODILY SECRETIONS; CACO-2 CELLS; CELL COMMUNICATION; CELLULAR MICROENVIRONMENT; FEMALE; HUMANS; IMMUNITY, CELLULAR; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; MIDDLE AGED; OXIDATION-REDUCTION; RNA, SMALL INTERFERING; THIOREDOXINS; YOUNG ADULT;

EID: 84884221399     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2013.17     Document Type: Article

References (50)

1. Harder, J., Glaser, R. & Schroder, J.M. Human antimicrobial proteins effectors of innate immunity. J. Endotoxin. Res. 13, 317-338 (2007).
2. Huttner, K.M. & Bevins, C.L. Antimicrobial peptides as mediators of epithelial host defense. Pediatr. Res. 45, 785-794 (1999).
3. Singh, P.K. et al. Production of beta-defensins by human airway epithelia. Proc. Natl. Acad. Sci. USA 95, 14961-14966 (1998).
4. Goldman, M.J., Anderson, G.M., Stolzenberg, E.D., Kari, U.P., Zasloff, M. & Wilson, J.M. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88, 553-560 (1997).
5. Zhao, C., Wang, I. & Lehrer, R.I. Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett. 396, 319-322 (1996).
6. McCray, P.B.J. & Bentley, L. Human airway epithelia express a beta-defensin. Am. J. Respir. Cell. Mol. Biol. 16, 343-349 (1997).
7. Tollin, M., Bergman, P., Svenberg, T., Jornvall, H., Gudmundsson, G.H. & Agerberth, B. Antimicrobial peptides in the first line defence of human colon mucosa. Peptides 24, 523-530 (2003).
8. Presicce, P., Giannelli, S., Taddeo, A., Villa, M.L. & Della, B.S. Human defensins activate monocyte-derived dendritic cells, promote the production of proinflammatory cytokines, and up-regulate the surface expression of CD91. J. Leukoc. Biol. 86, 941-948 (2009).
9. Kraemer, B.F. et al. Novel Anti-bacterial Activities of beta-defensin 1 in human platelets: Suppression of pathogen growth and signaling of neutrophil extracellular trap formation. PLoS Pathog. 7, e1002355 (2011).
10. Prado-Montes de Oca, E. Human b-defensin 1: A restless warrior against allergies, infections and cancer. Int. J. Biochem. Cell. Biol. 42, 800-804 (2010).
11. Kocsis, A.K. et al. Association of beta-defensin 1 single nucleotide polymorphisms with Crohn's disease. Scand. J. Gastroenterol. 43, 299-307 (2008).
12. Berg, R.D. The indigenous gastrointestinal microflora. Trends Microbiol. 4, 430-435 (1996).
13. Wilson, M. The gastrointestinal tract and its indigenous microbiota. In Microbial Inhabitants of Humans, 251-317; ISBN-13:9780521841580 (Cambridge University Press, Cambridge, 2005).
14. Glover, L.E. & Colgan, S.P. Hypoxia and metabolic factors that influence inflammatory bowel disease pathogenesis. Gastroenterology 140, 1748-1755 (2011).
15. Schroeder, B.O. et al. Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1. Nature 469, 419-423 (2011).
16. Scudiero, O. et al. Novel synthetic, salt-resistant analogs of human betadefensins 1 and 3 endowed with enhanced antimicrobial activity. Antimicrob. Agents Chemother. 54, 2312-2322 (2010).
17. Hogg, P.J. Disulfide bonds as switches for protein function. Trends Biochem. Sci. 28, 210-214 (2003).
18. Xie, L., Chesterman, C.N. & Hogg, P.J. Control of von Willebrand factor multimer size by thrombospondin-1. J. Exp. Med. 193, 1341-1349 (2001).
19. Azimi, I., Matthias, L.J., Center, R.J., Wong, J.W. & Hogg, P.J. Disulfide bond that constrains the HIV-1 gp120 V3 domain is cleaved by thioredoxin. J. Biol. Chem. 285, 40072-40080 (2010).
20. Matthias, L.J. et al. Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1. Nat. Immunol. 3, 727-732 (2002).
21. Wollman, E.E., Kahan, A. & Fradelizi, D. Detection of membrane associated thioredoxin on human cell lines. Biochem. Biophys. Res. Commun. 230, 602-606 (1997).
22. Rubartelli, A., Bonifaci, N. & Sitia, R. High rates of thioredoxin secretion correlate with growth arrest in hepatoma cells. Cancer Res. 55, 675-680 (1995).
23. Angelini, G. et al. Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc. Natl. Acad. Sci. USA 99, 1491-1496 (2002).
24. Rubartelli, A., Bajetto, A., Allavena, G., Wollman, E. & Sitia, R. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J. Biol. Chem. 267, 24161-24164 (1992).
25. Nakamura, H. et al. Chronic elevation of plasma thioredoxin: Inhibition of chemotaxis and curtailment of life expectancy in AIDS. Proc. Natl. Acad. Sci. USA 98, 2688-2693 (2001).
26. Gromer, S., Urig, S. & Becker, K. The thioredoxin system-from science to clinic. Med. Res. Rev. 24, 40-89 (2004).
27. Arner, E.S. & Holmgren, A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267, 6102-6109 (2000).
28. Mougiakakos, D., Johansson, C.C., Jitschin, R., Bottcher, M. & Kiessling, R. Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress. Blood 117, 857-861 (2011).
29. Mougiakakos, D., Johansson, C.C. & Kiessling, R. Naturally occurring regulatory Tcells show reduced sensitivity toward oxidative stress-induced cell death. Blood 113, 3542-3545 (2009).
30. Takeuchi, J. et al. Thioredoxin inhibits tumor necrosis factor- or interleukin-1-induced NF-kappaB activation at a level upstream of NF-kappaBinducing kinase. Antioxid. Redox. Signal. 2, 83-92 (2000).
31. Hirota, K. et al. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J. Biol. Chem. 274, 27891-27897 (1999).
32. Turano, C., Coppari, S., Altieri, F. & Ferraro, A. Proteins of the PDI family: Unpredicted non-ER locations and functions. J. Cell. Physiol. 193, 154-163 (2002).
33. Gallina, A. et al. Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry. J. Biol. Chem. 277, 50579-50588 (2002).
34. Lundberg, M., Fernandes, A.P., Kumar, S. & Holmgren, A. Cellular and plasma levels of human glutaredoxin 1 and 2 detected by sensitive ELISA systems. Biochem. Biophys. Res. Commun. 319, 801-809 (2004).
35. Peltoniemi, M.J. et al. Modulation of glutaredoxin in the lung and sputumof cigarettesmokers and chronic obstructive pulmonary disease. Respir. Res. 7, 133 (2006).
36. O'Keeffe, J. et al. Flow cytometric measurement of intracellular migration inhibition factor and tumour necrosis factor alpha in the mucosa of patients with coeliac disease. Clin. Exp. Immunol. 125, 376-382 (2001).
37. Roger, T., David, J., Glauser, M.P. & Calandra, T. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414, 920-924 (2001).
38. Kleemann, R. et al. Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase. J. Mol. Biol. 280, 85-102 (1998).
39. Curbo, S. et al. Regulation of interleukin-4 signaling by extracellular reduction of intramolecular disulfides. Biochem. Biophys. Res. Commun. 390, 1272-1277 (2009).
40. Peters-Golden, M. & Shelly, C. The oral gold compound auranofin triggers arachidonate release and cyclooxygenase metabolism in the alveolar macrophage. Prostaglandins 36, 773-786 (1988).
41. Du, Y., Zhang, H., Lu, J. & Holmgren, A. Glutathione and glutaredoxin act as backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose. J. Biol. Chem. 287, 38210-38219 (2012).
42. Jin, X. et al. Activation of extracellular transglutaminase 2 by thioredoxin. J. Biol. Chem. 286, 37866-37873 (2011).
43. Tamaki, H. et al. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production. Gastroenterology 131, 1110-1121 (2006).
44. Taniguchi, Y., Taniguchi-Ueda, Y., Mori, K. & Yodoi, J. A novel promoter sequence is involved in the oxidative stress-induced expression of the adult T-cell leukemia-derived factor (ADF)/human thioredoxin (Trx) gene. Nucleic Acids Res. 24, 2746-2752 (1996).
45. Maurice, M.M. et al. Expression of the thioredoxin-Thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum. 42, 2430-2439 (1999).
46. Watson, W., Heilman, J., Hughes, L. & Spielberger, J. Thioredoxin reductase-1 knock down does not result in thioredoxin-1 oxidation. Biochem. Biophys. Res. Commun. 368, 832-836 (2008).
47. Song, J.J., Rhee, J.G., Suntharalingam, M., Walsh, S.A., Spitz, D.R. & Lee, Y.J. Role of glutaredoxin in metabolic oxidative stress. Glutaredoxin as a sensor of oxidative stress mediated by H2O2. J. Biol. Chem. 277, 46566-46575 (2002).
48. Pan, S. & Berk, B.C. Glutathiolation regulates tumor necrosis factor-Alphainduced caspase-3 cleavage and apoptosis: Key role for glutaredoxin in the death pathway. Circ. Res. 100, 213-219 (2007).
49. Pazgier, M., Hoover, D.M., Yang, D., Lu, W. & Lubkowski, J. Human beta-defensins. Cell. Mol. Life Sci. 63, 1294-1313 (2006).
50. Chantret, I. et al. Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: Evidence for glucose-dependent negative regulation. J. Cell Sci. 107 (Pt 1), 213-225 (1994).